Skip to content

EyePoint, Inc. EYPT Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

LQD
Liquidia CorporationLQDA
$0-100%
Bausch + Lomb logo
Bausch + LombBLCO
$2.8B+5,504%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$250M

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+108%
Enterprise value$1.15B+122%
P/S158.5×+148×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.

The official record: EyePoint, Inc. ’s 10-K, filed March 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's debt issuance proceeds?
EyePoint, Inc. (EYPT) reported debt issuance proceeds of $0 in Q4 2024.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.